Drug Consumption Rooms are safe spaces where people can use drugs under hygienic conditions, with support, and without fear of violence or legal repercussions. Today, more than 140 legally-sanctioned DCRs operate in 11 European countries, as well as in Australia, Canada, Mexico and the USA. Join us on a global video tour to discover why they were established, how they support their local communities and how these life-saving harm reduction facilities have evolved over time.

The lucrative and unregulated market of semi-synthetic cannabinoids is rapidly expanding across Europe, raising public health concerns and posing a legislative challenge to policymakers. The solution lies not in prohibition but in regulation.

We present you the video recordings of the four webinars we organised in collaboration with the Correlation European Harm Reduction Network to strengthen harm reduction advocacy across Europe.

The UN drug treaties prohibited the use of coca leaf but Andean people are now promoting its re-legalisation. We asked Cesar Aguilar Alcedo, a member of the Bolivian delegation at the UN Commission on Narcotic Drugs, to explain why.

In this interview, filmed at the UN Commission on Narcotic Drugs, we discussed current developments of cannabis policy reform in Europe with Tom Blickman from the Transnational Institute.

Paul Stamets is a world-renowned mycologist, featured in the 2019 Netflix documentary, Fantastic Fungi. In our interview he explains why he thinks that psychedelic mushrooms can help humankind to survive the crisis of the 21th century.

In this interview, filmed at the 67th Commission on Narcotic Drugs in Vienna this year, we asked Arild Knutsen, the head of the Association for Humane Drug Policy (FHN) about drug policy reform developments in Norway.

You have likely heard of a new group of synthetic substances, Nitazines, increasingly sold on illicit drug markets in North America and in Europe. We interviewed Shayla Schlossenberg, Drug Service Coordinator at Release, a UK-based drug policy and human rights NGO.

We interviewed the renowned psychiatrist, Peter Gasser, who conducted the first clinical study on the therapeutic use of LSD after research on psychedelics was outlawed in the 1960s.

The recent backlash against the decriminalisation of drug use is a worrying sign of decision-makers’ short-sightedness. We, as a society, need to reconnect with marginalised people and not re-criminalise them.